Literature DB >> 25415384

Mortality, causes of death, and health status among methamphetamine users.

Diane M Herbeck1, Mary-Lynn Brecht, Katherine Lovinger.   

Abstract

This study examines causes of death, years of life lost, and health and drug use characteristics associated with mortality over an 8 to 10 year period in a sample of methamphetamine users who had and had not received substance use disorder treatment (N = 563). Decedents reported initiating their methamphetamine use for different reasons than surviving methamphetamine users, and some of these differences varied by treatment status. Study findings provide additional detail on long-term health and mortality outcomes in a diverse sample of methamphetamine users, which may inform public health strategies targeting the comparable and divergent needs of treated and untreated populations.

Entities:  

Keywords:  Methamphetamine; morbidity; mortality; substance use disorder treatment

Mesh:

Substances:

Year:  2014        PMID: 25415384      PMCID: PMC4684255          DOI: 10.1080/10550887.2014.975610

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  35 in total

1.  Frequent methamphetamine injection predicts emergency department utilization among street-involved youth.

Authors:  B D L Marshall; E Grafstein; J A Buxton; J Qi; E Wood; J A Shoveller; T Kerr
Journal:  Public Health       Date:  2011-11-30       Impact factor: 2.427

2.  All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study.

Authors:  Russell C Callaghan; James K Cunningham; Marina Verdichevski; Jenna Sykes; Sukaina R Jaffer; Stephen J Kish
Journal:  Drug Alcohol Depend       Date:  2012-04-13       Impact factor: 4.492

3.  Self-report of Longitudinal Substance Use: A Comparison of the UCLA Natural History Interview and the Addiction Severity Index.

Authors:  Debra A Murphy; Yih-Ing Hser; David Huang; Mary-Lynn Brecht; Diane M Herbeck
Journal:  J Drug Issues       Date:  2010-03

4.  A simple method to calculate the confidence interval of a standardized mortality ratio (SMR)

Authors:  K Ulm
Journal:  Am J Epidemiol       Date:  1990-02       Impact factor: 4.897

Review 5.  Major physical and psychological harms of methamphetamine use.

Authors:  Shane Darke; Sharlene Kaye; Rebecca McKetin; Johan Duflou
Journal:  Drug Alcohol Rev       Date:  2008-05

6.  Differences in Mortality among Heroin, Cocaine, and Methamphetamine Users: A Hierarchical Bayesian Approach.

Authors:  Li-Jung Liang; David Huang; Mary-Lynn Brecht; Yih-Ing Hser
Journal:  J Drug Issues       Date:  2010-12

7.  Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles.

Authors:  S B Karch; B G Stephens; C H Ho
Journal:  J Forensic Sci       Date:  1999-03       Impact factor: 1.832

8.  Causes of death of patients with methamphetamine dependence: a record-linkage study.

Authors:  Chian-Jue Kuo; Ya-Tang Liao; Wei J Chen; Shang-Ying Tsai; Shih-Ku Lin; Chiao-Chicy Chen
Journal:  Drug Alcohol Rev       Date:  2010-10-18

9.  Mortality associated with illegal drug use among adults in the United States.

Authors:  Pradip K Muhuri; Joseph C Gfroerer
Journal:  Am J Drug Alcohol Abuse       Date:  2011-05       Impact factor: 3.829

Review 10.  HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present.

Authors:  Karen F Corsi; Robert E Booth
Journal:  Curr Drug Abuse Rev       Date:  2008-11
View more
  17 in total

1.  Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis.

Authors:  Emily Stockings; Lucy Thi Tran; Thomas Santo; Amy Peacock; Sarah Larney; Damian Santomauro; Michael Farrell; Louisa Degenhardt
Journal:  Addiction       Date:  2019-07-28       Impact factor: 6.526

2.  GABAA receptor positive allosteric modulators modify the abuse-related behavioral and neurochemical effects of methamphetamine in rhesus monkeys.

Authors:  Laís F Berro; Monica L Andersen; Sergio Tufik; Leonard L Howell
Journal:  Neuropharmacology       Date:  2017-05-08       Impact factor: 5.250

3.  Assessment of tolerance to the effects of methamphetamine on daytime and nighttime activity evaluated with actigraphy in rhesus monkeys.

Authors:  Laís F Berro; Monica L Andersen; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2017-06-07       Impact factor: 4.530

4.  Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.

Authors:  Roham T Zamanian; Haley Hedlin; Paul Greuenwald; David M Wilson; Joshua I Segal; Michelle Jorden; Kristina Kudelko; Juliana Liu; Andrew Hsi; Allyson Rupp; Andrew J Sweatt; Rubin Tuder; Gerald J Berry; Marlene Rabinovitch; Ramona L Doyle; Vinicio de Jesus Perez; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

Review 5.  [Methamphetamine : Epidemiology, clinical importance and sequelae of abuse].

Authors:  N Arnaud; R Thomasius
Journal:  Nervenarzt       Date:  2017-09       Impact factor: 1.214

6.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

7.  Methamphetamine and cardiac disease among people with HIV infection.

Authors:  Tcs Martin; S Gianella; D Franklin; P Hsue; D M Smith
Journal:  HIV Med       Date:  2020-08-01       Impact factor: 3.180

Review 8.  Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.

Authors:  Ravi K Sajja; Shafiqur Rahman; Luca Cucullo
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-17       Impact factor: 6.200

Review 9.  Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  J Dual Diagn       Date:  2016

Review 10.  Responding to global stimulant use: challenges and opportunities.

Authors:  Michael Farrell; Natasha K Martin; Emily Stockings; Annick Bórquez; Javier A Cepeda; Louisa Degenhardt; Robert Ali; Lucy Thi Tran; Jürgen Rehm; Marta Torrens; Steve Shoptaw; Rebecca McKetin
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.